The study demonstrates that ABT-737 effectively induces apoptosis in HTLV-1–transformed cell lines and primary ATLL cells by targeting the BCL-2 anti-apoptotic members, thereby restoring the balance between pro- and anti-apoptotic signaling. This evidence concerns the gene BCL2 and adult T-cell leukemia/lymphoma.